PROCEPT BioRobotics reports annual meeting voting results; all proposals passed

Proposal 2 in the Proxy Statement, a proposal to ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, was approved by the following vote: Votes For Votes Withheld Abstentions 35,294,549 6,064 9,317

Proposal 3 in the Proxy Statement, an advisory vote on the frequency of future advisory votes on executive compensation, was approved at the frequency of "every one year", by the following vote: Every 1 Year Every 2 Years Every 3 Years Abstentions Broker Non-Votes 29,190,028 140,611 155,001 1,123 5,823,167

All of the nominees for director listed in Proposal 1 in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 26, 2023 (the “Proxy Statement”), were elected to serve on the Company’s board of directors until the Company’s 2026 annual meeting of stockholders, or until his or her successor is duly elected or appointed, by the following vote: Name of Nominee Votes For Votes Withheld Broker Non-Votes Frederic Moll, M.D. 29,347,415 139,348 5,823,167 Antal Desai 25,382,486 4,104,277 5,823,167 Mary Garrett 25,249,292 4,237,471 5,823,167